Business Description
Shelter Pharma Ltd
ISIN : INE013V01011
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.73 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 41.93 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 18.6 | |||||
Beneish M-Score | -0.3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.2 | |||||
3-Year FCF Growth Rate | -110.1 | |||||
3-Year Book Growth Rate | 71 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.64 | |||||
9-Day RSI | 44.71 | |||||
14-Day RSI | 45.11 | |||||
6-1 Month Momentum % | -19.09 | |||||
12-1 Month Momentum % | 9.79 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 20.15 | |||||
Quick Ratio | 13.42 | |||||
Cash Ratio | 3.42 | |||||
Days Inventory | 112.34 | |||||
Days Sales Outstanding | 80.66 | |||||
Days Payable | 5.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.72 | |||||
Forward Dividend Yield % | 0.72 | |||||
5-Year Yield-on-Cost % | 0.72 | |||||
Shareholder Yield % | -17.06 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.68 | |||||
Operating Margin % | 22.09 | |||||
Net Margin % | 15.49 | |||||
FCF Margin % | -6.75 | |||||
ROE % | 22.39 | |||||
ROA % | 19.8 | |||||
ROIC % | 23.94 | |||||
ROC (Joel Greenblatt) % | 40.28 | |||||
ROCE % | 30.19 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.58 | |||||
PE Ratio without NRI | 8.58 | |||||
PS Ratio | 1.33 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 1.49 | |||||
EV-to-EBIT | 5.74 | |||||
EV-to-EBITDA | 5.57 | |||||
EV-to-Revenue | 1.22 | |||||
EV-to-FCF | -18.44 | |||||
Price-to-Graham-Number | 0.75 | |||||
Price-to-Net-Current-Asset-Value | 1.93 | |||||
Price-to-Net-Cash | 18.11 | |||||
Earnings Yield (Greenblatt) % | 17.43 | |||||
FCF Yield % | -5.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shelter Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 400.229 | ||
EPS (TTM) (₹) | 5.36 | ||
Beta | 0 | ||
Volatility % | 72.43 | ||
14-Day RSI | 45.11 | ||
14-Day ATR (₹) | 2.017205 | ||
20-Day SMA (₹) | 46.9305 | ||
12-1 Month Momentum % | 9.79 | ||
52-Week Range (₹) | 38.01 - 80.9 | ||
Shares Outstanding (Mil) | 11.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shelter Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shelter Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Shelter Pharma Ltd Frequently Asked Questions
What is Shelter Pharma Ltd(BOM:543963)'s stock price today?
When is next earnings date of Shelter Pharma Ltd(BOM:543963)?
Does Shelter Pharma Ltd(BOM:543963) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |